ARTICLE | Company News
Shenzhen Kang Sheng Bao, SuperNova deal
April 4, 2011 7:00 AM UTC
Shenzhen and SuperNova partnered to develop and commercialize diagnostics and services in China for measuring neopterin, a biomarker of interferon (IFN) beta antiviral activity. SuperNova will use its...